Harvard Bioscience Debt to Equity Ratio 2012-2026 | HBIO
Current and historical debt to equity ratio values for Harvard Bioscience (HBIO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Harvard Bioscience debt/equity for the three months ending March 31, 2026 was 2.61.
| Harvard Bioscience Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $0.07B | $0.01B | 6.76 |
| 2025-12-31 | $0.07B | $0.01B | 4.83 |
| 2025-09-30 | $0.06B | $0.01B | 4.54 |
| 2025-06-30 | $0.06B | $0.02B | 4.09 |
| 2025-03-31 | $0.07B | $0.02B | 4.38 |
| 2024-12-31 | $0.06B | $0.06B | 1.00 |
| 2024-09-30 | $0.07B | $0.07B | 1.01 |
| 2024-06-30 | $0.06B | $0.07B | 0.92 |
| 2024-03-31 | $0.06B | $0.07B | 0.94 |
| 2023-12-31 | $0.06B | $0.07B | 0.88 |
| 2023-09-30 | $0.07B | $0.07B | 0.88 |
| 2023-06-30 | $0.07B | $0.08B | 0.90 |
| 2023-03-31 | $0.07B | $0.07B | 0.96 |
| 2022-12-31 | $0.07B | $0.07B | 1.01 |
| 2022-09-30 | $0.08B | $0.07B | 1.04 |
| 2022-06-30 | $0.08B | $0.08B | 1.00 |
| 2022-03-31 | $0.08B | $0.08B | 1.07 |
| 2021-12-31 | $0.08B | $0.08B | 0.95 |
| 2021-09-30 | $0.08B | $0.08B | 1.00 |
| 2021-06-30 | $0.08B | $0.08B | 0.96 |
| 2021-03-31 | $0.07B | $0.08B | 0.96 |
| 2020-12-31 | $0.08B | $0.08B | 1.04 |
| 2020-09-30 | $0.07B | $0.08B | 0.94 |
| 2020-06-30 | $0.08B | $0.08B | 0.98 |
| 2020-03-31 | $0.08B | $0.08B | 1.06 |
| 2019-12-31 | $0.08B | $0.08B | 1.02 |
| 2019-09-30 | $0.09B | $0.08B | 1.11 |
| 2019-06-30 | $0.09B | $0.08B | 1.07 |
| 2019-03-31 | $0.09B | $0.08B | 1.13 |
| 2018-12-31 | $0.09B | $0.08B | 1.04 |
| 2018-09-30 | $0.08B | $0.08B | 1.04 |
| 2018-06-30 | $0.09B | $0.08B | 1.14 |
| 2018-03-31 | $0.09B | $0.08B | 1.16 |
| 2017-12-31 | $0.03B | $0.08B | 0.35 |
| 2017-09-30 | $0.03B | $0.08B | 0.44 |
| 2017-06-30 | $0.03B | $0.08B | 0.45 |
| 2017-03-31 | $0.04B | $0.07B | 0.48 |
| 2016-12-31 | $0.04B | $0.07B | 0.49 |
| 2016-09-30 | $0.04B | $0.08B | 0.48 |
| 2016-06-30 | $0.04B | $0.08B | 0.49 |
| 2016-03-31 | $0.04B | $0.08B | 0.51 |
| 2015-12-31 | $0.04B | $0.08B | 0.55 |
| 2015-09-30 | $0.04B | $0.09B | 0.42 |
| 2015-06-30 | $0.04B | $0.10B | 0.46 |
| 2015-03-31 | $0.04B | $0.09B | 0.48 |
| 2014-12-31 | $0.04B | $0.10B | 0.42 |
| 2014-09-30 | $0.04B | $0.10B | 0.41 |
| 2014-06-30 | $0.04B | $0.10B | 0.40 |
| 2014-03-31 | $0.04B | $0.10B | 0.41 |
| 2013-12-31 | $0.04B | $0.09B | 0.43 |
| 2013-09-30 | $0.04B | $0.11B | 0.38 |
| 2013-06-30 | $0.04B | $0.11B | 0.39 |
| 2013-03-31 | $0.03B | $0.10B | 0.30 |
| 2012-12-31 | $0.03B | $0.10B | 0.28 |
| 2012-09-30 | $0.03B | $0.10B | 0.30 |
| 2012-06-30 | $0.03B | $0.10B | 0.32 |
| 2012-03-31 | $0.03B | $0.10B | 0.34 |
| 2011-12-31 | $0.03B | $0.10B | 0.33 |
| 2011-09-30 | $0.03B | $0.10B | 0.32 |
| 2011-06-30 | $0.03B | $0.10B | 0.33 |
| 2011-03-31 | $0.03B | $0.09B | 0.35 |
| 2010-12-31 | $0.04B | $0.09B | 0.38 |
| 2010-09-30 | $0.03B | $0.09B | 0.36 |
| 2010-06-30 | $0.03B | $0.08B | 0.36 |
| 2010-03-31 | $0.03B | $0.08B | 0.40 |
| 2009-12-31 | $0.03B | $0.08B | 0.43 |
| 2009-09-30 | $0.04B | $0.07B | 0.48 |
| 2009-06-30 | $0.01B | $0.07B | 0.18 |
| 2009-03-31 | $0.01B | $0.07B | 0.20 |
| 2008-12-31 | $0.02B | $0.07B | 0.22 |
| 2008-09-30 | $0.01B | $0.07B | 0.20 |
| 2008-06-30 | $0.02B | $0.08B | 0.24 |
| 2008-03-31 | $0.02B | $0.08B | 0.23 |
| 2007-12-31 | $0.03B | $0.07B | 0.33 |
| 2007-09-30 | $0.02B | $0.08B | 0.28 |
| 2007-06-30 | $0.02B | $0.07B | 0.24 |
| 2007-03-31 | $0.02B | $0.07B | 0.25 |
| 2006-12-31 | $0.02B | $0.07B | 0.30 |
| 2006-09-30 | $0.02B | $0.07B | 0.25 |
| 2006-06-30 | $0.02B | $0.07B | 0.29 |
| 2006-03-31 | $0.02B | $0.07B | 0.32 |
| 2005-12-31 | $0.02B | $0.07B | 0.34 |
| 2005-09-30 | $0.03B | $0.08B | 0.43 |
| 2005-06-30 | $0.03B | $0.07B | 0.45 |
| 2005-03-31 | $0.03B | $0.10B | 0.31 |
| 2004-12-31 | $0.04B | $0.10B | 0.34 |
| 2004-09-30 | $0.03B | $0.10B | 0.33 |
| 2004-06-30 | $0.03B | $0.10B | 0.34 |
| 2004-03-31 | $0.04B | $0.10B | 0.36 |
| 2003-12-31 | $0.03B | $0.10B | 0.30 |
| 2003-09-30 | $0.03B | $0.09B | 0.27 |
| 2003-06-30 | $0.03B | $0.09B | 0.27 |
| 2003-03-31 | $0.03B | $0.09B | 0.30 |
| 2002-12-31 | $0.02B | $0.09B | 0.22 |
| 2002-09-30 | $0.01B | $0.07B | 0.18 |
| 2002-06-30 | $0.01B | $0.07B | 0.17 |
| 2002-03-31 | $0.02B | $0.07B | 0.22 |
| 2001-12-31 | $0.02B | $0.07B | 0.23 |
| 2001-09-30 | $0.01B | $0.07B | 0.12 |
| 2001-06-30 | $0.01B | $0.07B | 0.13 |
| 2001-03-31 | $0.01B | $0.06B | 0.08 |
| 2000-12-31 | $0.01B | $0.05B | 0.12 |
| 2000-09-30 | $0.02B | $0.01B | 2.06 |
| 2000-06-30 | $0.00B | 0.00 | |
| 2000-03-31 | $0.00B | 0.00 | |
| 1999-12-31 | $0.01B | $0.01B | 1.58 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |